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ABBREVIATIONS 
AASM  american academy of sleep medicine 
ECG  echocardiogram 
HF  high frequency  
HRV  heart rate variability 
ICP  intracranial pressure  
IH   intracranial hypertension  
IQR  interquartile range 
LF  low frequency  
LF/HF ratio low frequency/high frequency ratio 
LR  likelihood ratio 
LR+  positive likelihood ratio 
NREM non-rapid eye movement  
oAHI  obstructive apnea-hypopnea index 
OCT  optical coherence tomography 
ODI  oxygen desaturation index 
OSA  obstructive sleep apnea  
OSAS  obstructive sleep apnea syndrome 
PSG  polysomnography  
RA  respiratory arrhythmia  
REM  rapid eye movement  
RERA  respiratory effort related arousal  
SpO2  oxygen-hemoglobin desaturations on pulse oximetry  
SWS   slow wave sleep  
TST  total sleep time  
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UARS  upper airway resistance syndrome  
 
  
ABSTRACT 
Background In the spectrum of children with symptomatic sleep disordered breathing 
(SDB), some individuals – such as those with upper airway resistance syndrome 
(UARS) – do not have abnormalities on polysomnography (PSG). In this study we have 
assessed whether assessment of respiratory arrhythmia (RA) and heart rate variability 
(HRV) analysis helps in management of children with syndromic craniosynostosis and 
none-to-mild obstructive sleep apnea (OSA).  
Methods Prospective cohort study in children aged 1 to 18 years old with syndromic 
craniosynostosis. Children were selected for HRV analysis from the ECG if their 
obstructive apnea-hypopnea index (oAHI) was between zero and five per hour (i.e., 
oAHI ≤5/hour). Subjects were divided into  groups based on the presence or absence of 
respiratory arrhythmia (with or without RA respectively) using the electrocardiogram 
(ECG). The main analysis included studying the relationship between RA and HRV, 
symptoms, interventions, and sleep architecture.  
Results We identified 42 patients with, at worst, mild OSA. We found higher 
parasympathetic control and higher total power  in children with RA during the non-rapid 
eye movement (non-REM) sleep. Children with RA also have a relatively higher 
percentage of paradoxical breathing non-REM sleep (p=0.042). Intracranial 
hypertension was distributed equally between groups. Last, RA patients showed 
increased parasympathetic activity that further increased in non-REM sleep.  
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Conclusion In syndromic craniosynostosis cases with SDB and PSG showing oAHI 
≤5/hour, the presence of RA may indicate subsequent need for treatment interventions, 
and a trend toward higher occurrence of clinical symptoms. ECG analyses of HRV 
variables in subjects with RA demonstrate increased parasympathetic activity and total 
power. Such findings may add to the diagnosis of apparently asymptomatic children. 
 
KEYWORDS 
Sleep disordered breathing; Obstructive sleep apnea; Polysomnography; Respiratory 
arrhythmia; Heart rate variability; Craniosynostosis  
 
INTRODUCTION 
Craniosynostosis is a congenital disorder characterized by premature fusion of skull 
sutures which can be part of a syndrome such as Apert, Crouzon, Muenke or Saethre-
Chotzen syndrome.(1) Two-thirds of these children have sleep disordered breathing 
(SDB), particularly obstructive sleep apnea (OSA).(2) In such children OSA is mainly 
caused by a combination of anatomical abnormalities of the upper airway at the level of 
the tongue base and palate, as well as decreased pharyngeal muscular tone during 
sleep. Symptoms include sleep-associated apnea, snoring, frequent awakenings, 
sweating, enuresis, and daytime sleepiness. Of note, apnea and oxygen-hemoglobin 
desaturations on pulse oximetry (SpO2) induce tonic activation of chemoreflex activity, 
and an increase in sympathetic nerve activity, which causes sympathetic 
predominance.(3-7) In the daytime, there may be headaches, behavioral changes and 
daytime tiredness, which can lead to physical, functional and social impairment.(8)  
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Within the spectrum of sleep-disordered breathing (SDB) in children with 
craniosynostosis severe OSA necessitates treatment, whereas the consequences of 
mild OSA are less clear. Moderate forms of SDB, like the upper airway resistance 
syndrome (UARS),(9) are considered when there are symptoms of OSA, yet no 
abnormality on polysomnography (PSG). These children suffer from a partially 
obstructed upper airway, but recognizable obstructive events or abnormal respiratory 
gas exchange is not observed.(10) Common symptoms are snoring, increased 
respiratory effort, and frequent arousals. Together, these problems may cause tiredness 
during the day and excessive sleepiness. Given that UARS is more common than 
OSA(10, 11), the use of OSA indicators to assess severity may underestimate UARS in 
children.(9, 11, 12)  
Since there is a need for refining the clinical evaluation in cases of 
craniosynostosis with milder forms of SDB, we reasoned that an indirect, non-invasive 
approach to diagnosis using changes in respiratory arrhythmia (RA) and changes in the 
heart rate variability (HRV) may be of value. RA shows the absolute difference in heart 
rate above or below baseline heart rate. HRV describes the variations between 
consecutive heartbeats and is decreased in patients with OSA.(13-16) Currently, HRV is 
only used as a warning sign for myocardial infarction and diabetic neuropathy, but it can 
be used to assess autonomic balance(17-19), which may be important in understanding 
the pathophysiology of SDB.(14, 20-24) As a secondary outcome we assessed 
interventions and intracranial hypertension in this sample. We hypothesize that children 
with RA are more likely to undergo interventions and acquire intracranial hypertension.  
METHODS 
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Patients 
The Ethics Committee of the Erasmus Medical Center (MEC-2005-273) approved this 
human subjects study of post hoc analysis of data collected from a prospective, 
observational cohort (enrollment period March 2012 to March 2016) at the Dutch 
Craniofacial Center (Sophia Children’s Hospital – Erasmus University Medical Center, 
Rotterdam, The Netherlands). We included children aged between 1 and 18 years with 
syndromic (i.e., Apert, Crouzon, Muenke, Saethre-Chotzen syndromes, based on 
genetic analysis), or complex craniosynostosis (defined as multiple suture synostoses in 
which no genetic cause is found yet), or unicoronal craniosynostosis.  
Polysomnography  
All patients had undergone overnight, in-hospital, level 1 PSG that included assessment 
of the following cardiorespiratory and neurophysiologic variables: nasal airflow 
(thermistor), chest and abdominal wall motion, SpO2, transcutaneous partial pressure of 
carbon dioxide, and electrocardiogram (ECG). PSG data were analyzed using Shell+ 
BrainRT Software (Suite Version 2.0;O.S.G. Rumst, Belgium), using ECG frequency of 
250Hz for sampling. A study was considered suitable for analysis if it provided a total 
sleep time (TST) of at least 360 minutes, free of artifact. Respiratory events were 
scored using the American Academy of Sleep Medicine (AASM) criteria.(25)  
An obstructive event was defined as a reduction in nasal airflow of ≥90% 
(apnea) or 30-90% (hypopnea), for at least two breaths, in the presence of thoracic and 
abdominal breathing movement. Hypopnea was only included in the analysis if it was 
associated with a subsequent SpO2-desaturation of at least 3% from baseline, or with 
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an arousal. Central apnea/hypopnea meets the same criteria as the above obstructive 
event definition, but without the presence of thoracic and abdominal breathing 
movement. A mixed apnea had to meet the central apnea criteria and be associated 
with absence, in one part, and presence, in the other part, of thoracic and abdominal 
breathing movement. The oxygen desaturation index (ODI) was assessed by dividing 
the total number of SpO2 desaturations by the TST in hours.(25) A respiratory effort 
related arousal (RERA) was defined as the sequence of breaths lasting at least 10 
seconds which did not meet criteria for an apnea or hypopnea and was characterized by 
increasing respiratory effort leading to an arousal from sleep. Sleep quality (i.e., sum of 
rapid eye movement [REM] sleep and slow wave sleep [SWS or N3] divided by the 
TST) and sleep efficiency (i.e., TST divided by the time in bed [TIB]) were also 
evaluated. EEG is performed to score the sleep stage.(25, 26) In the current report, 
children were selected for HRV analysis from the ECG if their obstructive apnea-
hypopnea index (oAHI) was between zero and five per hour (i.e., oAHI ≤5/hour).  
Paradoxical breathing is present when the child’s thoracic and abdominal 
movements are not synchronous. It is considered a sensitive indicator for increased 
airway resistance.(27) Even though it may be normal physiology, in children with 
breathing problems the percentage of paradoxical breathing is higher. Respiration was 
assessed as paradoxical if the lowest peak of the chest motion was synchronous with 
the highest peak of the abdominal motion, and vice versa. The percentage of 
paradoxical breathing was calculated using the duration of paradoxical breathing 
divided by the TST, and multiplied by 100.  
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 Respiratory arrhythmia (RA) was defined as an absolute difference in heart 
rate of more than 10 beats per minute change above or below baseline heart rate.  
Outcome variables  
Clinical evaluations comprised of the five symptoms assessed from patient 
records, divided into two main groups; breathing and sleep abnormalities, at the time of 
PSG. These were assesses as followed: breathing abnormalities; snoring, audible 
breathing, and oral breathing, and sleep abnormalities; restless sleep and tiredness. 
Subjects were categorized as having symptoms if at least one of the above was 
present, no difference was made in the total number of symptoms with which the child 
was presenting. Any intervention, or treatment, in relation to timing of OSA and PSG 
was also recorded. These interventions included surgical interventions (i.e., 
adenotonsillectomy , midface advancement [monobloc, facial bipartition, or Le Fort III] 
mandibular advancement, nasal septum correction, and maxillary widening), and non-
surgical interventions (i.e., nasal corticosteroid spray)(28). We also assessed whether 
these children suffered from intracranial hypertension.  In our protocol(29-33), all 
patients were routinely screened for the presence of symptoms/signs related to possible 
intracranial hypertension, including: downward deflection of the occipital-frontal head 
circumference growth trajectory; and, papilledema diagnosed by a pediatric 
ophthalmologist with a funduscopic examination or optical coherence tomography 
(OCT). In some cases, invasive intracranial pressure (ICP) monitoring was carried out. 
The determination of “intracranial hypertension” used in the current report was based on 
assessments made near the time of the PSG (± 3 months) and follow-up at 1 year after 
PSG (± 3 months).   
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Assessment of HRV 
HRV was determined by measuring the RR-interval of the ECG-signal using Kubios 
HRV software (Biosignal Analysis and Medical Imaging Group (BSAMIG), Department 
of Applied Physics, University of Eastern Finland, Kuopio, FINLAND) (17)  HRV 
variables were analyzed using the time and frequency domains, as well as by using 
non-linear analysis (Table 1). For the frequency domain analysis the frequency bands 
were set as followed: LF; 0.04−0.15 Hz, and HF (0.15−0.4 Hz).  
In order to analyze the HRV data, we divided the PSG dataset into 2 minute 
epochs, that were artifact-free during both REM and non-REM (NREM) sleep 
stages.(16) This approach allowed evaluation of persistent changes in HRV after 
respiratory events, without other events potentially influencing heart rate.(13, 17, 34-36) 
Artifacts were defined as respiratory events (i.e., apnea, hypopnea, arousals, SpO2 
desaturation ≥3%), sighs, and movements during sleep.   
 
Statistical analysis  
Non-parametric statistical methods were used based on the small sample size in each 
group and the not normally distribution of the RA-groups. Occurrence of symptoms was 
compared to the occurrence of RA. Variables were subsequently compared between 
groups, using either a chi-square test (expected value above 5) or fisher’s exact test 
(expected value below 5). The Mann Whitney U test was used for comparing continuous 
variables between two categorical variables. Variables with a P-value <0.05 was 
considered statistically significant. Results are presented as median (range) or median 
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(interquartile range [IQR]). Power calculation was not feasible without prior information. 
Hence, in the exploratory analyses of the impact of RA and HRV variables we describe 
sensitivity, specificity, likelihood ratio of a positive result (LR+), and changes from pre- 
to post-test probability of the outcome of interest. 
 
RESULTS 
We identified 42 craniosynostosis patients with oAHI ≤ 5/hour (30 cases with oAHI 
<1/hour; and, 12 cases with oAHI ≥1/hour). Their diagnoses were:  Apert (n=5), 
Crouzon (n=14), Muenke (n=2), Saethre Chotzen (n=4), complex craniosynostosis 
(n=9), and unicoronal synostosis (n=8). The mean age at time of PSG was 6.8 years 
(range: 1.0 – 18.0 years) and 45% (19/42) of cases were male.  
 
RA, clinical evaluation, and interventions 
On comparing those with and without RA, we found that RA was present in 22/42 
patients, and those with and without this phenomenon were similar in age (6.4 [IQR, 
3.5-9.3] versus 5.5 [1.7-10.5] years, P=0.80), and had similar baseline respiratory rate 
(17.0 [15.0-21.0] versus 18.0 [16.0-21.5] breaths/minute, P=0.21), see Table 2.  
Overall 31/42 (74% pre-test probability) had one or more symptoms. 86.4%(19/22) of 
the RA+ group had one or more symptoms compared with 60% (12/20) of the RA- 
group (P=0.052), see Table 3. On exploratory analysis, when considering the presence 
of RA as a “diagnostic test” of presence of one or more symptoms we found with a 
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sensitivity of 0.61, a specificity of 0.73, and a LR+ of 2.26, that the post-test probability 
of one or more symptoms was 86.4%. In regard to interventions, 21/42 (50% pre-test 
probability) underwent one or more interventions. 54.5% (12/22) of the RA+ group 
underwent one or more interventions, compared with 45.0% (9/20) of the RA- group 
(P=0.54), see Table 4. On exploratory analysis, when considering the presence of RA 
as a “diagnostic test” of subsequent interventions we found with a sensitivity of 0.57, a 
specificity of 0.48 and a LR+ of 1.1, that the post-test probability of subsequent 
intervention was 52,3%. Last, the occurrence of intracranial hypertension in the RA+ 
and RA- groups, at the time of the PSG (18% vs. 15%) and 1 year later (0.0% vs. 
0.0%), was no different (p=0.56 and 0.52, respectively)(see Table 5). 
HRV analysis  
In the HRV analysis (using time domain and non-linear analysis variables), there were 
significantly higher values for a range of variables during both NREM and REM sleep 
(Tables 6 and 7). In the frequency domain, high frequency (HF) was significantly higher 
and the low-to-high frequency ratio (LF/HF) was significantly lower in the RA+ group, 
during both sleep states. Also, in the frequency domain, the total power of the frequency 
bands during the NREM sleep was significantly higher in the RA+ group (4970.0 vs. 
1334.0, p=0.011)(Table 6).  A higher percentage of paradoxical breathing during NREM 
sleep was found in the RA+ group, compared with the RA- group (19.0% versus 9.2%, 
P=0.042) (see Table 2). There was no difference in sleep characteristics between both 
groups (see Table 2).   
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DISCUSSION 
In this pilot study of children with syndromic craniosynostosis and primary snoring to 
mild OSA (oAHI ≤5/hour) we have made two significant observations. First, in about 
one-half of the patients in our practice, RA was evident in the PSG test. Second, the 
presence of RA+ in non-to-mild OSA may be indicative of higher parasympathetic 
activity, particularly during NREM sleep. Taken together, these data provide important 
insight into the pathophysiology of SDB during NREM sleep in patients with syndromic 
craniosynostosis.   
In our study we found that children with RA had a trend toward more clinical 
symptoms. It was remarkable that we did not find any differences in sleep architecture, 
as we have reported in more severe cases of SDB in craniosynostosis.(2, 8, 37) It could 
be argued that symptoms were not severe enough to alter sleep architecture. Also, we 
did not find a difference in rate of finding IH. However, on closer inspection of HRV we 
did make some key observations.  
 In the analyses of different HRV variables we found that the RA+ group had 
higher HF and a lower LF/HF ratio, which means that there was increased 
parasympathetic activity compared to the RA- group. This finding makes sense since 
the HF power is driven by the parasympathetic activity, which in turn is associated with 
respiratory activity. This physiology may account for have overriding or possible 
limitation in  increased sympathetic activity associated with OSA.(38, 39) Comparing 
this finding to previous studies of children who actually have OSA, a higher level of 
sympathetic activity is the usual finding. Liao et al.(14) compared children with none-or-
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mild SDB with children with moderate-or-worse SDB and found that the more severe 
cases exhibited impaired HRV with excess sympathetic and weaker parasympathetic 
activity. Muzumdar et al.(13) showed increased sympathetic activity in children with 
OSA before adenotonsillectomy; after adenotonsillectomy there was an improvement in 
SDB and the level of sympathetic activity decreased.  The most important difference 
between these studies and our current report is that study participants were children 
without a chronic condition, and our subjects all had syndromic craniosynostosis. 
However, we have not excluded the possibility that our subjects had some explanation 
for impairment of cardiac autonomic modulation as part of their underlying syndrome.  
 During two different states (NREM versus REM) we found that NREM disclosed 
a further shift to parasympathetic activity in the RA+ group. Liao et al.(16) reported a 
shift in cardiac autonomic modulation across sleep stages in children without SDB: a 
shift towards parasympathetic control from wake-to-NREM sleep, and a shift towards 
sympathetic control on entering REM sleep. Also, in cases of mild SDB, there was a 
similar pattern across sleep stages.(16) Therefore, in common with our study, during 
REM sleep there is less parasympathetic control. Also we found that in NREM sleep 
total power is significantly higher in children with RA;  by implication, this group has to 
put significantly more effort in maintaining hemodynamic stability during NREM sleep. In 
addition, in children with RA we have identified a higher percentage of paradoxical 
breathing during NREM sleep. We speculate that this finding may, therefore, be caused 
by relatively higher parasympathetic activity in NREM sleep.  
A possible explanation for the fact that the RA+ group had increased parasympathetic 
activity compared to the RA- group might be that the severity and the duration of the 
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RA+ group may not yet be sufficient enough to impact autonomic modulation in the RA+ 
group.(16) This may therefore be a predictive finding for OSA in the clinical evaluation.  
Another explanation can be found in the normal physiology of  healthy subjects.(40) 
Intense or acute activation of the autonomic nervous system in combination with acute 
changes in blood pressure lead to higher risk for arrhythmias and SDB.(40-42) This is 
caused by changes in impulse generation and oxygen metabolism of the heart or in the 
baroreflex function.(40, 42) Therefore, RA might be caused by the interactions in the 
sympathetic and parasympathetic system. Adrenergic stimulation will increase 
automaticity of Purkinje fibers and when the vagal nerve is activated on a background of 
enhanced automaticity sinus rate is reduced.(40) A question remains, however; whether 
changes in sympathetic and parasympathetic activity in the RA+ group are related to 
changes in blood pressure in different sleep stages or to a difference in autonomic 
modulation, which might be specifically different in these children.  
 Our study is not without limitations. First, in an ideal physiological assessment we 
should compare HRV analyses with esophageal pressure monitoring, so as to quantify 
airway flow-limitation.(43) This technique is too invasive for our clinical subjects and 
protocol.(43) Therefore, we are unable to identify cases of UARS (i.e., moderate SDB 
with symptoms of OSA and no abnormality on PSG). However, we have used the oAHI 
index as a biomarker of severity in airflow limitation and identified a subgroup in which 
interventions for OSA are more likely – that may be likened to UARS, albeit with the 
circuitous definition of those with RA. Second, we have not carried out systematic 
assessment of patient symptoms, but rather used the report of clinical symptoms 
recorded in the clinical notes. Third, our study group encompasses a wide age range (1 
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to 18 years) and, as such, we may have missed some relationship between symptom 
severity and significance, and the evolution of airway development. Fourth, we have not 
compared our data with a control group but rather studied graded-severity within a 
subset of cases with craniosynostosis. A control group might have given us reference 
values for the HRV variables. Last, due to the small sample size we were obligated to 
use non-parametric statistical testing which is less reliable to detect a real effect.   
 In conclusion, in patients with syndromic craniosynostosis, SDB and PSG 
showing oAHI ≤5/hour, the presence of RA may indicate a trend toward higher 
occurrence of clinical symptoms. Furthermore analysis of HRV variables in subjects with 
RA demonstrates an increase in parasympathetic activity that changes more during 
NREM sleep. Therefore, ECG analyses for RA and HRV variables may be a potentially 
useful aid in the present diagnostic work-up  of apparently asymptomatic children with 
syndromic craniosynostosis screened for SDB.  
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TABLES 
Table 1 HRV measures  Non-linear analysis (Poincare plot): the Poincare HRV plot 
is a graph in which each RR interval (X-axis) is plotted against the next RR 
interval (Y-axis) as a type of “delay map” 
Analysis Variable Definition  
Time domain 
analysis 
SDNN The standard deviation (SD) of the normal-to-normal [NN] 
intervals, i.e., all intervals between adjacent QRS complexes 
resulting from sinus node depolarization. The SDNN reflects 
both short and long term variation within the RR interval 
series, and is an estimate of overall HRV 
 RMSSD The square root of the mean squared differences of 
successive NN intervals, which is a measure of short-term 
variability 
 RRti HRV triangular index which is the integral of the density 
distribution divided by the maximum of the density 
distribution, and is an estimate of overall HRV 
Frequency 
domain 
analysis 
LF Low frequency components, which are mainly from 
sympathetic origin, but may also arise from parasympathetic 
activity 
 HF High frequency components (arising from respiratory sinus 
arrhythmia [RSA] and breathing), which are of 
parasympathetic origin 
 LF/HF 
ratio 
The ratio of low-to-high frequency power components, which 
reflects autonomic balance 
 TP Total power, a measure of the total power of all frequency 
components  
Non-linear 
analysisa  
SD1 SD1 is the dispersion (standard deviation) of points 
perpendicular to the axis of line-of-identity and gives a 
measure of short-term variability 
 SD2 SD2 is the dispersion (standard deviation) of points along the 
axis of line-of identity and gives a measure of long-term 
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variability  
 
Table 2 Demographics 
Variable With 
RA(mean(IQR)) 
Without 
RA(median(IQR)) 
P-value 
Age (years) 6.4(3.5-9.3) 5.5(1.7-10.5) 0.80 
Respiratory rate 
(/min) 
17.0(15.0-21.0) 18.0(16.0-21.5) 0.21 
Mean heart rate 
(/min) 
81.5(73.7-90.3) 83.9(72.0-106.2) 0.47 
ODI (events/h) 1.8(0.6-5.4) 1.4(0.9-2.7) 0.49 
Sleepquality(%) 47.3(39.0-53.1) 44.9(36.0-51.7) 0.45 
Sleepefficiency(%) 85.4(77.7-91.6) 79.2(68.3-86.3) 0.09 
Arousalindex 0.0(0.0-1.2) 0.0(0.0-4.2) 0.46 
Awakenings(n) 6.5(4.0-9.8) 8.0(5.5-16.5) 0.12 
RERA/TST(n) 5.5(1.8-8.5) 6.5(2.3-10.8) 0.40 
Paradoxical 
breathing(%) 
14.5(6.5-33.8) 11.0(3.3-19.3) 0.26 
Paradoxical 
breathing, 
NREM(%) 
12.5(4.8-25.8) 2.0(0.0-14.8) 0.042 
Paradoxical 
breathing, REM(%) 
26.0(8.0-35.0) 30.5(0.3-48.5) 0.31 
RA, respiratory arrhythmia; ODI, oxygen desaturation index; RERA; respiratory effort 
related arousal, IQR; interquartile range  
 
Table 3 Symptom assessment 
Symptom 
assessment 
With 
RA(n=22) 
Without 
RA(n=20) 
Symptoms With 
RA(n=22) 
Without 
RA(n=20) 
Breathing 
abnormalities(%) 
86.4(19/22) 55.0(11/20) Snoring(%) 68.1(15/22)  45.0(9/20) 
   Audible 
breathing(%) 
54.5(12/22) 20.0(4/20) 
   Oral 
breathing(%)  
22.7(5/22) 0.0(0/20) 
Sleep 
abnormalities(%) 
45.5(10/22) 35.0(7/20) Restless 
sleep(%)  
45.5(10/22) 30.0(6/20) 
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RA, respiratory arrhythmia; n, group size 
 
Table 4 Intervention assessment 
*Intervention  With RA(n=22) Without RA(n=20) P-value (chi-
square) 
Surgical(%)  40.9(9/22) 35.0(7/20)  
Non-surgical(%)  22.7(5/22) 20.0(4/20)  
Total(%) 54.5(12/22) 45.0(9/20) 0.54 
RA, respiratory arrhythmia; n, group size 
*One child can be scored more than once, because of a combination treatment of 
surgical and non-surgical interventions 
 
Table 5 Intracranial hypertension occurrence at time of PSG and 1 years post 
PSG 
Variable  With RA Without RA  P-value (Fisher’s 
exact) 
IH at time of PSG(%) 18 15 0.56 
IH 1 year post PSG(%) 0.05 0 0.52 
RA, respiratory arrhythmia; IH, intracranial hypertension; PSG, polysomnography 
 
 
Table 6 HRV variables in the time domain, non-linear, and frequency domain 
analyses during NREM sleep 
Symptoms 
total(%) 
86.4(19/22) 60.0(12/20) Tiredness(%) 27.3(6/22) 25.0(5/20) 
Variable With RA 
(median(IQR)) 
Without RA 
(median(IQR)) 
P-value  
SDNN 73.8(45.3-94.0) 37.75 (23.8-62.4) 0.013 
RMSSD 87.6(45.7-120.0) 44.3(25.2-74.3) 0.017 
RRti 19.1(11.9-26.4) 9.8(5.9-17.3) 0.00 
SD1 62.2(32.5-85.1) 31.4(18.0-52.8) 0.02 
SD2 106.8(75.8-135.1) 69.7(56.5-112.6) 0.09 
LF 915.5(343.0-1831.5) 490.5(213.5-1294.5) 0.18 
HF 3680.0(1196.8-
6475.8) 
793.5(281.5-2492.5) 0.00 
LF/HF ratio 0.3(0.2-0.3) 0.6(0.4-1.1) 0.00 
TP 4970.0(1763.5-
8488.0) 
1334.0(493.3-3916.5) 0.011 
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RA, respiratory arrhythmia; SDNN, standard deviation of the normal to normal intervals; 
RMSSD, square root of the mean squared differences of successive NN intervals; RRti, 
HRV triangular index; LF, low frequency; HF, high frequency, IQR; interquartile range, 
TP; total power  
 
Table 7 HRV variables in the time domain, non-linear, and frequency domain 
analyses during REM sleep 
RA, respiratory arrhythmia; SDNN, standard deviation of the normal to normal intervals; 
RMSSD, square root of the mean squared differences of successive NN intervals; RRti, 
HRV triangular index; LF, low frequency; HF, high frequency, IQR; interquartile range, 
TP; total power  
 
 
Variable With RA 
(median(IQR)) 
Without RA 
(median(IQR)) 
P-value  
SDNN 55.0(34.9-80.2) 40.0(24.2-50.4) 0.039 
RMSSD 62.5(39.1-104.5) 41.5(22.1-55.3) 0.023 
RRti 12.1(8.4-17.8) 7.9(5.1-12.1) 0.045 
SD1 44.5(27.8-74.3) 29.6(15.7-39.4) 0.025 
SD2 98.0(66.6-129.4) 72.1(50.9-105.5) 0.096 
LF 903.0(407.8-1616.5) 564.0(246.5-996.8) 0.212 
HF 1675.5(668.3-
4297.3) 
600.0(180.5-1377.3) 0.019 
LF/HF ratio 0.5(0.3-0.6) 0.9(0.6-1.3) 0.002 
TP 2977.5(1052.8-
6443.3) 
1211.0(478.5-2428.5) 0.060 
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Electrocardiographic variables in children with syndromic craniosynostosis and 
none-to-mild obstructive sleep apnea: significance of identifying respiratory 
arrhythmia during sleep 
Highlights 
• Increased parasympathetic activity and total power is shown in children with 
respiratory arrhythmia in the non-rapid eye movement sleep.  
• Among children with respiratory arrhythmia there is a higher percentage of 
paradoxical breathing during the non-rapid eye movement sleep.  
• Intracranial hypertension is distributed equally between children with and without 
respiratory arrhythmia.  
 
